JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 1995; 25:1347-1353
© 1995 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Murgatroyd, F.
Right arrow Articles by Camm, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Murgatroyd, F.
Right arrow Articles by Camm, A.

Efficacy and tolerability of transvenous low energy cardioversion of paroxysmal atrial fibrillation in humans

FD Murgatroyd, AK Slade, SM Sopher, E Rowland, DE Ward, and AJ Camm

St. George's Hospital Medical School, London, England, United Kingdom.

OBJECTIVES. This study investigated the efficacy and tolerability of low energy shocks for termination of atrial fibrillation in patients, using an endocardial electrode configuration that embraced both atria. BACKGROUND. In animals, low energy biphasic shocks delivered between electrodes in the coronary sinus and right atrium have effectively terminated atrial fibrillation. If human defibrillation thresholds are sufficiently low, atrial defibrillation could be achieved in conscious patients using an implanted device. METHODS. Twenty-two consecutive patients with stable atrial fibrillation were studied during electrophysiologic testing. Biphasic R wave synchronous shocks were delivered between large surface area electrodes in the coronary sinus and high right atrium, using a step-up voltage protocol starting at 10 or 20 V and increasing to a maximum of 400 V. Patients were conscious at the start of the study and were asked to report on symptoms but were sedated later if shocks were not tolerated. RESULTS. Cardioversion was achieved in all 19 patients who completed the study, with a mean (+/- SD) leading-edge voltage of 237 +/- 55 V (range 140 to 340) and mean energy of 2.16 +/- 1.02 J (range 0.7 to 4.4). The mean maximal shock delivered without sedation was 116 +/- 51 V (range 60 to 180). No proarrhythmia or mechanical complications occurred. CONCLUSIONS. The delivery of biphasic R wave synchronous shocks between the high right atrium and coronary sinus can terminate atrial fibrillation with very low energies. General anaesthesia is not required, and a minority of fully conscious patients are able to tolerate this method of cardioversion.


This article has been cited by other articles:


Home page
HeartHome page
G. Haywood and B. Nuta
Getting the BEST out of DCCV
Heart, July 1, 2008; 94(7): 830 - 831.
[Full Text] [PDF]


Home page
EuropaceHome page
S. J. Walsh, G. Manoharan, O. J. Escalona, J. Santos, N. Evans, J. McC. Anderson, M. Stevenson, J. D. Allen, and A.A. J. Adgey
Novel rectangular biphasic and monophasic waveforms delivered by a radiofrequency-powered defibrillator compared with conventional capacitor-based waveforms in transvenous cardioversion of atrial fibrillation.
Europace, October 1, 2006; 8(10): 873 - 880.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
Writing Committee Members, V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, et al.
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Europace, September 1, 2006; 8(9): 651 - 745.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al.
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
J. Am. Coll. Cardiol., August 15, 2006; 48(4): e149 - e246.
[Full Text] [PDF]


Home page
CirculationHome page
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al.
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Circulation, August 15, 2006; 114(7): e257 - e354.
[Full Text] [PDF]


Home page
Eur Heart JHome page
J.C. Geller, S. Reek, C. Timmermans, T. Kayser, H.-F. Tse, C. Wolpert, W. Jung, A.J. Camm, C.-P. Lau, H. J.J. Wellens, et al.
Treatment of atrial fibrillation with an implantable atrial defibrillator -- long term results
Eur. Heart J., December 1, 2003; 24(23): 2083 - 2089.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. Manoharan, N. Evans, B. Kidwai, D. Allen, J. Anderson, and J. Adgey
Novel Passive Implantable Atrial Defibrillator Using Transcutaneous Radiofrequency Energy Transmission Successfully Cardioverts Atrial Fibrillation
Circulation, September 16, 2003; 108(11): 1382 - 1388.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
N. Sulke, P. Spurrell, K. Kamalvand, A. Mitchell, M. Higson, J. Gill, and V. Paul
The effect of endocardial defibrillator shocks on basic atrial electrophysiology in man: Is post cardioversion atrial electrical 'remodelling' artefact?
Europace, January 1, 2003; 5(1): 33 - 37.
[Abstract] [PDF]


Home page
EuropaceHome page
A. R. J. Mitchell, P. A. R. Spurrell, K. Kamalvand, M. Higson, R. Shanmuganathan, N. R. Patel, and N. Sulke
What is the optimal electrode configuration for atrial defibrillators in man?
Europace, January 1, 2002; 4(1): 41 - 44.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. M. Gallagher, X.-H. Guo, J. D. Poloniecki, Y. Guan Yap, D. Ward, and A. J. Camm
Initial energy setting, outcome and efficiency in direct current cardioversion of atrial fibrillation and flutter
J. Am. Coll. Cardiol., November 1, 2001; 38(5): 1498 - 1504.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
Guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology
Eur. Heart J., October 2, 2001; 22(20): 1852 - 1923.
[PDF]


Home page
J Am Coll CardiolHome page
V. Fuster, L. E. Ryden, R. W. Asinger, D. S. Cannom, H. J. Crijns, R. L. Frye, J. L. Halperin, G. N. Kay, W. W. Klein, S. Levy, et al.
ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology
J. Am. Coll. Cardiol., October 1, 2001; 38(4): 1266 - 1266.
[Full Text] [PDF]


Home page
Eur Heart JHome page
R.E. Ideker and P.C. Fotuhi
Early atrial defibrillation; 'a stitch in time saves nine' or 'haste makes waste'?
Eur. Heart J., September 1, 2001; 22(17): 1524 - 1526.
[PDF]


Home page
Eur Heart JHome page
P.E. Vardas, E.G. Manios, E.M. Kanoupakis, D.N. Dermitzaki, H.E. Mavrakis, and E.M. Kallergis
Atrial defibrillation threshold in humans minutes after atrial fibrillation induction. 'a stitch in time saves nine'
Eur. Heart J., September 1, 2001; 22(17): 1613 - 1617.
[Abstract] [PDF]


Home page
CirculationHome page
X. Zheng, M. E. Benser, G. P. Walcott, and R. E. Ideker
Right Atrial Septal Electrode for Reducing the Atrial Defibrillation Threshold
Circulation, August 28, 2001; 104(9): 1066 - 1070.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
A. Andraghetti and M. Scalese
Safety and efficacy of low-energy cardioversion of 500 patients using two different techniques
Europace, January 1, 2001; 3(1): 4 - 9.
[Abstract] [PDF]


Home page
EuropaceHome page
S. Levy
Internal cardioversion. Is it needed? How best to perform it?
Europace, January 1, 2001; 3(2): 87 - 89.
[PDF]


Home page
EuropaceHome page
G. Gasparini, A. Bonso, S. Themistoclakis, F. Giada, and A. Raviele
Low-energy internal cardioversion in patients with long-lasting atrial fibrillation refractory to external electrical cardioversion: results and long-term follow-up
Europace, January 1, 2001; 3(2): 90 - 95.
[Abstract] [PDF]


Home page
CirculationHome page
X. Zheng, M. E. Benser, G. P. Walcott, S. D. Girouard, D. L. Rollins, W. M. Smith, and R. E. Ideker
Reduction of Atrial Defibrillation Threshold With an Interatrial Septal Electrode
Circulation, November 21, 2000; 102(21): 2659 - 2664.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. G. Daoud, C. Timmermans, C. Fellows, R. Hoyt, R. Lemery, K. Dawson, and G. M. Ayers
Initial Clinical Experience With Ambulatory Use of an Implantable Atrial Defibrillator for Conversion of Atrial Fibrillation
Circulation, September 19, 2000; 102(12): 1407 - 1413.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
G. Boriani, M. Biffi, V. Cervi, G. Bronzetti, G. Magagnoli, R. Zannoli, and A. Branzi
Evaluation of Myocardial Injury Following Repeated Internal Atrial Shocks by Monitoring Serum Cardiac Troponin I Levels
Chest, August 1, 2000; 118(2): 342 - 347.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
M. Santini, C. Pandozi, F. Colivicchi, F. Ammirati, M. Carmela Scianaro, A. Castro, F. Lamberti, and G. Gentilucci
Transoesophageal low-energy cardioversion of atrial fibrillation. Results with the oesophageal-right atrial lead configuration
Eur. Heart J., May 2, 2000; 21(10): 848 - 855.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
C. Timmermans, S. Levy, G. M. Ayers, W. Jung, L. Jordaens, M. Rosenqvist, B. Thibault, J. Camm, L.-M. Rodriguez, H. J. J. Wellens, et al.
Spontaneous episodes of atrial fibrillation after implantation of the Metrix Atrioverter: observations on treated and nontreated episodes
J. Am. Coll. Cardiol., May 1, 2000; 35(6): 1428 - 1433.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
G L Botto, A Politi, W Bonini, T Broffoni, and R Bonatti
External cardioversion of atrial fibrillation: role of paddle position on technical efficacy and energy requirements
Heart, December 1, 1999; 82(6): 726 - 730.
[Abstract] [Full Text]


Home page
CirculationHome page
C. Timmermans, A. Nabar, L.-M. Rodriguez, G. Ayers, and H. J. J. Wellens
Use of Sedation During Cardioversion With the Implantable Atrial Defibrillator
Circulation, October 5, 1999; 100(14): 1499 - 1501.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
H-F Tse, C-P Lau, and G M Ayers
Incidence and modes of onset of early reinitiation of atrial fibrillation after successful internal cardioversion, and its prevention by intravenous sotalol
Heart, September 1, 1999; 82(3): 319 - 324.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. Cooklin, M. R. Olsovsky, R. G. Brockman, S. R. Shorofsky, and M. R. Gold
Atrial defibrillation with a transvenous lead: A randomized comparison of active can shocking pathways
J. Am. Coll. Cardiol., August 1, 1999; 34(2): 358 - 362.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
H.-F. Tse, C.-P. Lau, B. M. Yomtov, and G. M. Ayers
Implantable atrial defibrillator with a single-pass dual-electrode lead
J. Am. Coll. Cardiol., June 1, 1999; 33(7): 1974 - 1980.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. Timmermans, L.-M. Rodriguez, G. M. Ayers, H. Lambert, J. L. R. M. Smeets, J. W. S. Vlaeyen, A. Albert, and H. J. J. Wellens
Effect of Butorphanol Tartrate on Shock-Related Discomfort During Internal Atrial Defibrillation
Circulation, April 13, 1999; 99(14): 1837 - 1842.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C.-P. Lau, H.-F. Tse, and G. M. Ayers
Defibrillation-guided radiofrequency ablation of atrial fibrillation secondary to an atrial focus
J. Am. Coll. Cardiol., April 1, 1999; 33(5): 1217 - 1226.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H.-F. Tse, C.-P. Lau, J. S. Sra, H. J. G. M. Crijns, N. Edvardsson, S. Kacet, and D. G. Wyse
Atrial Fibrillation Detection and R-Wave Synchronization by Metrix Implantable Atrial Defibrillator : Implications for Long-Term Efficacy and Safety
Circulation, March 23, 1999; 99(11): 1446 - 1451.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
G. Boriani, M. Biffi, A. Capucci, G. Bronzetti, G. M. Ayers, R. Zannoli, A. Branzi, and B. Magnani
Favorable effects of flecainide in transvenous internal cardioversion of atrial fibrillation
J. Am. Coll. Cardiol., February 1, 1999; 33(2): 333 - 341.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
V. Taramasco, A. Socas, P. Ricard, and S. Levy
Internal low-energy cardioversion: A therapeutic option for restoring sinus rhythm in chronic atrial fibrillation after failure of external cardioversion
Europace, January 1, 1999; 1(3): 179 - 182.
[Abstract] [PDF]


Home page
HeartHome page
N. S PETERS
Atrial fibrillation: towards an understanding of initiation, perpetuation, and specific treatment
Heart, December 1, 1998; 80(6): 533 - 534.
[Full Text]


Home page
CirculationHome page
H. J. J. Wellens, C.-P. Lau, B. Luderitz, M. Akhtar, A. L. Waldo, A. J. Camm, C. Timmermans, H.-F. Tse, W. Jung, L. Jordaens, et al.
Atrioverter: An Implantable Device for the Treatment of Atrial Fibrillation
Circulation, October 20, 1998; 98(16): 1651 - 1656.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. L. Waldo
Low-Energy Atrial Defibrillation : A Promising New Technique
Circulation, September 1, 1998; 98(9): 833 - 834.
[Full Text] [PDF]


Home page
CirculationHome page
R. A. S. Cooper, V. J. Plumb, A. E. Epstein, G. N. Kay, and R. E. Ideker
Marked Reduction in Internal Atrial Defibrillation Thresholds With Dual-Current Pathways and Sequential Shocks in Humans
Circulation, June 30, 1998; 97(25): 2527 - 2535.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
K Hnatkova, F D Murgatroyd, C A Alferness, A J Camm, and M Malik
Distribution of fast heart rate episodes during paroxysmal atrial fibrillation
Heart, May 1, 1998; 79(5): 497 - 501.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
H. Mehmanesh, R. Lange, and S. Hagl
Temporary Atrial Electrode for the Treatment of Supraventricular Tachycardia After Cardiac Operations
Ann. Thorac. Surg., March 1, 1998; 65(3): 632 - 636.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. A. S. Cooper, W. M. Smith, and R. E. Ideker
Internal Cardioversion of Atrial Fibrillation : Marked Reduction in Defibrillation Threshold With Dual Current Pathways
Circulation, October 21, 1997; 96(8): 2693 - 2700.
[Abstract] [Full Text]


Home page
CirculationHome page
E. T. Keelan, D. Krum, J. Hare, K. Mughal, H. Li, M. Akhtar, and M. R. Jazayeri
Safety of Atrial Defibrillation Shocks Synchronized to Narrow and Wide QRS Complexes During Atrial Pacing Protocols Simulating Atrial Fibrillation in Dogs
Circulation, September 16, 1997; 96(6): 2022 - 2030.
[Abstract] [Full Text]


Home page
CirculationHome page
M. C. Sokoloski, G. M. Ayers, K. Kumagai, C. M. Khrestian, S. Niwano, and A. L. Waldo
Safety of Transvenous Atrial Defibrillation : Studies in the Canine Sterile Pericarditis Model
Circulation, August 19, 1997; 96(4): 1343 - 1350.
[Abstract] [Full Text]


Home page
CirculationHome page
S. Levy, P. Ricard, M. Gueunoun, F. Yapo, J. Trigano, C. Mansouri, and F. Paganelli
Low-Energy Cardioversion of Spontaneous Atrial Fibrillation : Immediate and Long-term Results
Circulation, July 1, 1997; 96(1): 253 - 259.
[Abstract] [Full Text]


Home page
CirculationHome page
R. A. S. Cooper, E. E. Johnson, and J. M. Wharton
Internal Atrial Defibrillation in Humans : Improved Efficacy of Biphasic Waveforms and the Importance of Phase Duration
Circulation, March 18, 1997; 95(6): 1487 - 1496.
[Abstract] [Full Text]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 1995 by the American College of Cardiology Foundation.